‘We can no longer vouch for the veracity of the primary data sources.’
Authors of a Lancet study on hydroxychloroquine treatment of COVID-19 have retracted their findings, as WHO announces it will resume its trial A study published in The Lancet has been …
‘Dear Australia…’
Pharmacy groups sign joint open letter to Australians urging them to catch up on missed healthcare More than 20 national organisations have signed a joint open letter urging Australians not …
Pharmacists warned over fake scripts
When faced with a recent deluge of fraudulent scripts for fentanyl and OxyContin, the majority of pharmacists did not comply with legislative and professionals responsibilities, says DHHS The Victorian Pharmacy …
‘No paper, no repeats and no staples lying around.’
The first pharmacist in Australia to dispense an e-script shares his learnings from transitioning his pharmacy to the new electronic model Pharmacist Jason Bratuskins dispensed Australia’s first paperless electronic prescription …
March saw pre-Christmas script volume ‘three times over’
The COVID-19 crisis has sped up the e-scripts revolution in Australia and while pharmacists should be ready for the impending changes, “there’s no need to panic,” says expert E-prescriptions are …
TWC scores top points during busy March
While pharmacies across Australia have been pulling out all stops during the COVID-19 pandemic, one particular chain shines in customer satisfaction TerryWhite Chemmart (TWC) is the Pharmacy of the Month …
Questions raised over research
A group of researchers, statisticians and clinicians, including doctors and pharmacists, have called for an independent audit and review of The Lancet’s large hydroxychloroquine study Last month, a large observational …
Reprimands, complaints up compared to previous quarter
The VPA conducted 20 panel hearings in the first three months of this year alone, with 12 of these resulting in a reprimand and eight in a caution The Victorian …
Biologic treatment for severe asthma listed on PBS
A new pre-filled autoinjector for at-home administration of mepolizumab will be reimbursed by the PBS from 1 June Patients with severe refractory eosinophilic asthma can now choose to receive treatment …
Rural pharmacies fill gap left by doctor shortages
Temporary measures allowing community pharmacists to provide one-month supply of a patient’s regular medication when they can’t get a script should be made permanent, argues rural group While COVID-19 and …
Combination inhaler PBS listed for mild asthma
Symbicort is now PBS-listed for any form of asthma severity – mild, moderate or severe. So how should this change your conversations with patients asking for an OTC blue puffer? …
‘It’s essential that people feel safe to speak up.’
What’s the best way to support your pharmacy team during the pandemic? A recent webinar from AJP and PSS provides some valuable advice This week AJP and the Pharmacists’ Support …